Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis (Q27692668)

main subject

reproductive medicine

0 references

0 references

1 reference

1 reference

Potdar N

1

1 reference

Gelbaya TA

series ordinal

2

1 reference

Konje JC

series ordinal

3

1 reference

Nardo LG

series ordinal

4

1 reference

language of work or name

English

0 references

publication date

2013

1 reference

Human Reproduction Update

published in

1 reference

volume

19

1 reference

page(s)

674-84

1 reference

issue

6

1 reference

Endometrial gene expression analysis at the time of embryo implantation in women with unexplained infertility

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Increased rates of thrombophilia in women with repeated IVF failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

The role of thrombophilia and thyroid autoimmunity in unexplained infertility, implantation failure and recurrent spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

The role of low-molecular-weight heparin in recurrent implantation failure: a prospective, quasi-randomized, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Placental-specific IGF-II is a major modulator of placental and fetal growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Methylenetetrahydrofolate reductase C677T and A1298C variants do not affect ongoing pregnancy rates following IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Investigation of the effects of heparin and low molecular weight heparin on E-cadherin and laminin expression in rat pregnancy by immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Why differentiate low molecular weight heparins for venous thromboembolism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Interferon-gamma and tumor necrosis factor-alpha sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Heparin and low-molecular-weight heparins modulate the decidualization of human endometrial stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Profiling the gene signature of endometrial receptivity: clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Heparin prevents programmed cell death in human trophoblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Expression and activity of matrix metalloproteinase 2 and 9 in human trophoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Aspirin plus heparin or aspirin alone in women with recurrent miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Low-molecular-weight heparin in women with repeated implantation failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Investigation and treatment of repeated implantation failure following IVF-ET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Association of maternal and fetal MTHFR A1298C polymorphism with the risk of pregnancy loss: a study of an Indian population and a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

The potential role of heparin in assisted conception

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Effect of dalteparin sodium administration on IVF outcome in non-thrombophilic young women: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Thrombophilic disorders and fetal loss: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Recurrent implantation failure: definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Effect of heparin on the outcome of IVF treatment: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Repeated implantation failure: clinical approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantation failure and antiphospholipid or antinuclear antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

The effects of heparin-binding epidermal growth factor-like growth factor on preimplantation-embryo development and implantation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032

Time of implantation of the conceptus and loss of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMT032